Actively Recruiting
Global Healthcare Study on Psoriasis
Led by Julia Tatjana Maul · Updated on 2026-06-08
9600
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
J
Julia Tatjana Maul
Lead Sponsor
U
University of Zurich
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting the Global Healthcare Study on Psoriasis, an international observational study hosted by the University of Zurich. This study aims to examine healthcare access, treatment patterns, disease severity, and quality of life among patients with psoriasis. By collecting standardized clinical data from various healthcare systems, the study seeks to identify differences in healthcare delivery and patient outcomes worldwide. The study uses a combined approach, gathering both retrospective and prospective data from routine clinical care and medical records starting from January 2020 until the study ends. Participants include patients diagnosed with psoriasis, and no investigational treatments are administered as this is an observational study focused on data collection. Participants will have their clinical information, including disease severity and quality of life, recorded at baseline and followed up every 6 to 12 months for up to five years. Measurements include the Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), Nail Psoriasis Severity Index (NAPSI), Numerical Rating Scale for disease severity, Physician Global Assessment, and Body Surface Area affected. The study monitors these outcomes over time using routine clinical visits and medical records to understand the disease and treatment experiences better.
CONDITIONS
Brief Title
Global Healthcare Study on Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed General Consent Form, or equivalent document
- Confirmed diagnosis of Psoriasis
- Aged 14 years or older
You will not qualify if you...
- Inability to provide informed consent
- Datasets with ambiguous or unclear diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants who undergo routine care are observed with assessments to monitor psoriasis severity and quality of life.
Baseline and follow-up visits every 6 to 12 months
Trial Site Locations
Total: 1 location
1
University of Zurich
Zurich, Switzerland
Actively Recruiting
Research Team
J
Julia-Tatjana Maul
J
Johannes A Didaskalu, Prof. Dr. med.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here